How effective is Vigabatrin/vigabatrin generic drug in treating epilepsy?

Vigabatrin/vigabatrin is an anti-epileptic drug with a similar structure to γ-aminobutyric acid (GABA). It mainly works by irreversibly inhibiting GABA transaminase, thereby enhancing the concentration of GABA in the central nervous system and inhibiting abnormal brain electrical activity. Vigabatrin is commonly used to treat special types of epilepsy such as refractory focal epilepsy and infantile spasms. After the patent period expires, many countries have launched multiple versions of generic drugs, which have become an important supplementary option for clinical treatment in terms of efficacy, safety and accessibility.

Generic drugs must meet strict drug regulatory agency approval standards in terms of active ingredients, dosage forms, and bioavailability. For example, the USFDA, EU EMA and WHO have all set pharmacokinetic equivalence requirements for generic drugs. Therefore, in actual clinical practice, generic vigabatrin drugs can usually achieve similar therapeutic effects as the original drug. A large amount of clinical data shows that generic drugs are not inferior to original drugs in controlling the frequency of epileptic seizures, reducing the intensity of seizures and improving the quality of life, and their application effects in children are widely recognized.

Common sources of generic drugs currently on the market include Laos Daxiong Pharmaceutical, Laos ASEAN Pharmaceutical, Bangladesh Everest Pharmaceutical, Yaopin International, etc. Most of these manufacturers have internationalGMP certification, and their products are widely sold in South Asia, Southeast Asia, the Middle East and other regions. Taking the Lao version as an example, the common specifications are 500mg tablets or oral solutions. The price is significantly lower than that of the original drug. The monthly treatment cost can be controlled within 100 yuan, which provides great financial support for people who take medicine for a long time. It is worth mentioning that, on the premise that the ingredients of generic drugs and original drugs are basically the same, it is particularly important to purchase drugs from regular channels to avoid treatment delays caused by the use of unregistered imitations.

Reference materials:https://www.sabril.net/